Quick News Spot

JSR Wins As Fed. Circ. Axes Cytiva Antibody Isolation Patents - Law360


JSR Wins As Fed. Circ. Axes Cytiva Antibody Isolation Patents - Law360

By Ryan Davis ( December 4, 2024, 7:38 PM EST) -- In a precedential opinion, the Federal Circuit held Wednesday that all the claims that JSR Corp. challenged in three Cytiva Bioprocess antibody isolation patents are invalid as obvious, backing the Patent Trial and Appeal Board's invalidation of many claims while reversing its decision to uphold others....

Previous articleNext article

POPULAR CATEGORY

corporate

4724

tech

4045

entertainment

5863

research

2673

misc

6230

wellness

4731

athletics

6114